Latest
Enhanced Group is not a good investment now because the risks are huge. The freshly de-SPACed owner of the Enhanced Games, where athletes on performance-enhancing drugs compete for $25M, has largely prospective revenue, a violently volatile price and regulatory, reputational and liability exposure with no clean comparable. The long-term case for a new category spanning sport, performance medicine, telehealth and media rights could be huge, but space, AI and defense names offer enough upside. x.comÂ
